Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvio Danese

Showing results (1-10 of 1,196) with videos related to

Pageof 120
Sort By:
Inflammatory Bowel Diseases|May 5, 2011
Adalimumab for ulcerative colitis: a little is better than none?Silvio Danese
World Journal of Gastroenterology|February 26, 2011
What's hot in inflammatory bowel disease in 2011?Silvio Danese
Current Opinion in Gastroenterology|June 5, 2007
Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flowSilvio Danese
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 13, 2008
Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlightSilvio Danese
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 7, 2012
Adalimumab in ulcerative colitis: ready for prime timeSilvio Danese
Gut|November 26, 2011
New therapies for inflammatory bowel disease: from the bench to the bedsideSilvio Danese
Gut|January 8, 2011
Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: 'brothers in arms'Silvio Danese
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 15, 2011
Immune and nonimmune components orchestrate the pathogenesis of inflammatory bowel diseaseSilvio Danese
Trends in Immunology|October 8, 2008
Nonimmune cells in inflammatory bowel disease: from victim to villainSilvio Danese
Gastroenterology|December 22, 2019
New Drugs in the Ulcerative Colitis Pipeline: Prometheus UnboundSilvio Danese
Pageof 120

Showing results (1-10 of 1,196) with videos related to

Sort By:
Pageof 120
Inflammatory Bowel Diseases|May 5, 2011
Adalimumab for ulcerative colitis: a little is better than none?Silvio Danese
World Journal of Gastroenterology|February 26, 2011
What's hot in inflammatory bowel disease in 2011?Silvio Danese
Current Opinion in Gastroenterology|June 5, 2007
Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flowSilvio Danese
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 13, 2008
Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlightSilvio Danese
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 7, 2012
Adalimumab in ulcerative colitis: ready for prime timeSilvio Danese
Gut|November 26, 2011
New therapies for inflammatory bowel disease: from the bench to the bedsideSilvio Danese
Gut|January 8, 2011
Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: 'brothers in arms'Silvio Danese
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 15, 2011
Immune and nonimmune components orchestrate the pathogenesis of inflammatory bowel diseaseSilvio Danese
Trends in Immunology|October 8, 2008
Nonimmune cells in inflammatory bowel disease: from victim to villainSilvio Danese
Gastroenterology|December 22, 2019
New Drugs in the Ulcerative Colitis Pipeline: Prometheus UnboundSilvio Danese
Pageof 120